SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?


To: Gary Mohilner who wrote (5500)6/6/2012 1:13:44 PM
From: rjk01  Read Replies (1) | Respond to of 5665
 
C gave imgn thumb up but to be fair I dont have high opinion of him
Here is Ohad A to my post ASCO imgn Q
Ohad Hammer Says:
June 6th, 2012 at 3:16 am IMGN - I think the price fully represents T-DM1’s royalty stream in the metastatic setting. We need another clinical candidate with an efficacy signal to push the stock higher, that could happen next year.